すべての画像(2)
About This Item
実験式（ヒル表記法）:
Nd
CAS番号:
分子量:
144.24
MDL番号:
UNSPSCコード:
12352300
PubChem Substance ID:
NACRES:
NA.23
アッセイ
99.9%
フォーム
wire
メーカー／製品名
Goodfellow 692-616-33
抵抗性
64.0 μΩ-cm, 20°C
L ×直径
200 mm × 1 mm
bp
3074 °C (lit.)
mp
1021 °C (lit.)
密度
7.003 g/mL at 25 °C (lit.)
SMILES記法
[Nd]
InChI
1S/Nd
InChI Key
QEFYFXOXNSNQGX-UHFFFAOYSA-N
類似した製品をお探しですか？ 訪問 製品比較ガイド
詳細
For updated SDS information please visit www.goodfellow.com.
法的情報
Goodfellow製品
保管分類コード
4.1B - Flammable solid hazardous materials
WGK
WGK 3
引火点(°F)
Not applicable
引火点(℃)
Not applicable
最新バージョンのいずれかを選択してください：
A J Costello et al.
European urology, 35(2), 138-146 (1999-02-06)
Not until 1991 did laser therapy for benign prostatic hyperplasia become a feasible option for the practicing urologist. Prior to the development of side firing free beam laser delivery devices contact Neodymium:YAG, laser therapy for BPH was of limited applicability.
Franz Fankhauser et al.
Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde, 216(6), 381-398 (2003-02-05)
The physical and clinical features of a number of laser energy sources presently being used in plastic and endonasal surgery, such as the Nd:YAG, KTP, Ho:YAG, Er:YAG and CO(2) lasers, are emphasized. Particular attention is paid to the Nd:YAG laser
Francisco J Muñoz-Negrete et al.
BioMed research international, 2015, 742792-742792 (2015-11-12)
Uveitic glaucoma (UG) typically is associated with very high intraocular pressure (IOP) and more intense optic nerve damage than other glaucoma types. This secondary glaucoma requires an early diagnosis and adequate management of both uveitis and glaucoma. It is mandatory
B S Stein
Mayo Clinic proceedings, 73(8), 787-791 (1998-08-14)
Since 1986, benign prostatic hyperplasia has been treated with lasers, but clinical use was not practical until the right-angled fiber was developed in the early 1990s. The neodymium:yttrium-aluminum-garnet (Nd:YAG) laser is one of four types available for treating the prostate.
B C Patel et al.
Ophthalmology, 104(7), 1191-1197 (1997-07-01)
Laser-assisted dacryocystorhinostomy (DCR) has failed to match the success rates of external DCR. It has been suggested that this technology may be best suited for revision of failed DCR cases. The authors prospectively evaluated the efficacy of transcanalicular laser-assisted revision
ライフサイエンス、有機合成、材料科学、クロマトグラフィー、分析など、あらゆる分野の研究に経験のあるメンバーがおります。.
製品に関するお問い合わせはこちら（テクニカルサービス）